Mount Sinai receives $8 million from DataPhilanthropy to accelerate drug discovery for CADASIL and related brain disorders Sep 17 Written by Fanny Elahi Fanny Elahi Previous Previous Blood biomarkers may help early detection of Alzheimer’s Next Next Debating on the clinical utility of blood-based biomarkers for Alzheimer diagnosis
Mount Sinai receives $8 million from DataPhilanthropy to accelerate drug discovery for CADASIL and related brain disorders Sep 17 Written by Fanny Elahi Fanny Elahi
